BioInformant

Your Global Leader in Stem Cell Market Research

You are here: Home / Archives for cord blood

The Future of Stem Cell Therapy as Treatment for Autism

By 2 Comments

Treatment for autism is an increasingly important pursuit, as the Center for Disease Control and Prevention (CDC) estimates:

  • 1 in 59 children has been identified with autism spectrum disorder (ASD) [Read article]
  • Autism occurs in all racial, ethnic, and socioeconomic groups. [Read article]
  • Studies in Asia, Europe, and North America have identified ASD to have a prevalence rate of between 1% and 2%. [Data table]

With autism spectrum disorder (ASD) affecting between 1-2% of the population, the condition is becoming of increasing importance and a treatment for autism is becoming a highly sought-after medical breakthrough. [Read more…]

Famicord, Europe’s Largest Cord Blood Bank, and India’s CelluGen, Sign Letter of Intent

By Leave a Comment

FamiCord Group, the largest cord blood bank in Europe, and CelluGen Biotech, a biotech company headquartered in Gurgaon, India, have signed a letter of intent (LOI) to cooperate across a range of business activities. Dated April 25, 2019, the specifics of the LOI state that the companies will pursue cooperation within the “field of family cord blood banking of stem cells and the use of stem cells in experimental and standard therapies.” The companies may jointly develop ATMPs and drugs. [Read more…]

ExCellThera’s Cell Expansion Technology, ECT-001, Receives FDA RMAT Designation

By Leave a Comment

ExcelltheraMONTREAL, April 23, 2019 — ExCellThera Inc., an advanced clinical stage biotechnology company delivering molecules and bioengineering solutions to expand stem and immune cells for therapeutic use, announced today that the U.S. Food and Drug Administration (FDA) has granted regenerative medicine advanced therapy (RMAT) designation to its lead technology, ECT-001, in the treatment of hematologic malignancies. The RMAT designation is based on strong data from Phase I/II clinical trials using ECT-001 to expand stem and immune cells for the treatment of blood cancers. [Read more…]

PBKM (Famicord) May Acquire Esperite NV (Cryo-Save) Stem Cell Banking Business

By

Amsterdam, the Netherlands – 22 February 2019 — Esperite N.V. (Euronext: ESP) and Polski Bank Komórek Macierzystych S.A. (WSE: PBKM) are pleased to announce that they have entered into an Memorandum of Understanding (MoU) regarding the potential acquisition by PBKM of substantially all Cryo-Save’s business related to stem cell banking (the Proposed Acquisition). The Proposed Acquisition leverages the respective strengths and quality standards of the two publicly traded companies that are both leading in the stem cell banking sector. Cryo-Save is one of the largest and longest operating stem cell bank in Europe, in which store more than 330.000 umbilical cord blood samples and tissues. [Read more…]

Americord announces five-compartment bags and best-in-industry quality guarantee

By

New York, NY; February 19, 2019 — Americord Registry announced today that it will begin offering five-compartment freezing bags for all new customers storing cord blood as well as the highest quality guarantee in the industry. While industry-standard freezing bags typically contain two compartments, one holding eighty percent of the cord blood and a second holding twenty percent, Americord’s new freezing bags contain five compartments with twenty percent of the cord blood in each compartment. [Read more…]

BioInformant's World-Class Clients